EIF5A2 anticorps (C-Term)

N° du produit ABIN966053

Détail du produit anti-EIF5A2 anticorps

Antigène: EIF5A2 (Eukaryotic Translation Initiation Factor 5A2 (EIF5A2))

Épitope: C-Term

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EIF5A2 est non-conjugé

Application: Immunohistochemistry (IHC)

Immunogène: Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of human EIF5A2

Information d'application

Restrictions: For Research Use only

Stockage

Stock: 4 °C

Références pour anticorps anti-EIF5A2 (ABIN966053)

Luo, Hua, Rao, Liao, Kung, Zeng, Guan, Chen, Xie: "Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder." dans: Cancer science, Vol. 100, Issue 5, pp. 896-902, (2009) (PubMed).

Chen, Luo, Hua, Zhou, Lin, Kung, Zeng, Guan, Xie: "Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy." dans: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 18, Issue 2, pp. 400-8, (2009) (PubMed).

Yang, Xie, Liu, Luo, Li, Hua, Wu, Kung, Zeng, Guan: "Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma." dans: Gynecologic oncology, Vol. 112, Issue 2, pp. 314-8, (2009) (PubMed).

Xie, Ma, Pan, Wu, Liu, Wu, Kung, Guan: "Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma." dans: Human pathology, Vol. 39, Issue 1, pp. 80-6, (2007) (PubMed).

Ojima, Inoue, Miki, Mori, Kusunoki: "Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy." dans: Journal of gastroenterology, Vol. 42, Issue 9, pp. 730-6, (2007) (PubMed).

Andersen, Lam, Leung, Ong, Lyon, Lamond, Mann: "Nucleolar proteome dynamics." dans: Nature, Vol. 433, Issue 7021, pp. 77-83, (2005) (PubMed).

Guan, Fung, Ma, Lau, Tai, Xie, Zhang, Hu, Wu, Fang, Sham: "Oncogenic role of eIF-5A2 in the development of ovarian cancer." dans: Cancer research, Vol. 64, Issue 12, pp. 4197-200, (2004) (PubMed).

Détails sur EIF5A2

Antigène: EIF5A2 (Eukaryotic Translation Initiation Factor 5A2 (EIF5A2))

Autre désignation: EIF5A2 (EIF5A2 Produits)

Synonymes: anticorps EIF5A2, anticorps EIF5A, anticorps zgc:55504, anticorps zgc:77429, anticorps wu:fb05b06, anticorps wu:fc23f04, anticorps wu:fc61c10, anticorps EIF-5A2, anticorps eIF5AII, anticorps 9630038B20, anticorps eukaryotic translation initiation factor 5A2, anticorps eukaryotic translation initiation factor 5A3, anticorps EIF5A2, anticorps eif5a2, anticorps LOC100499632, anticorps Eif5a2

Sujet: EIF5A2 (Eukaryotic initiation factor 5A ) stimulates ribosomal peptidyltransferase activity, transport of HIV-1-mRNAs and binds exportins 1 and 4. Contains hypusine at lys 50. Human EIF5A1 and EIF5A2 encode two isoforms: eIF5AI and eIF5AII. Increased expression of EIF-5A2 in ovarian carcinoma may represent an acquired malignant phenotypic feature of tumor cells. Overexpression of EIF5A2 is an independent molecular marker for shortened survival time of patients with ovarian carcinoma.